Personal tools

UBERON:0000479

From FANTOM5_SSTAR

Jump to: navigation, search

Name:tissue
Namespace:FANTOM
Definition:"Anatomical structure, that consists of similar cells and intercellular matrix, aggregated according to genetically determined spatial relationships." [CARO:0000043, CARO:MAH, FMA:9637]
Xrefs:
links:

AAO:0000607
AAO:0010054
AEO:0000043
BILA:0000043
CARO:0000043
EHDAA2:0003043
FBbt:00007003
FMA:9637
galen:Tissue
HAO:0000043
MA:0003002
MESH:A.10
ncithesaurus:Tissue
NIF_GrossAnatomy:birnlex_19
TAO:0001477
TGMA:0001844
WBbt:0005729
XAO:0003040

ZFA:0001477
Synonyms: "portion of tissue" EXACT [CARO:0000043]
"simple tissue" EXACT [AEO:0000043]
"tissue portion" EXACT []
Comments:This class was sourced from CARO, which was initially sourced from FMA. Nomenclature changes have been made. Note also AEO introduces a class AEO:0000013 'single-cell tissue'
Alt_id: UBERON:CARO_0000043-FBbt_00007003-XAO_0003040-ZFA_0001477
Subset: upper_level

Ontology association<br>Each term has an is_a parent in the Uberon Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to UBERON ontologies.<br><br>link to ontology dataset<br>data


Parents

is_a:UBERON:0010000(multicellular anatomical structure)
part_of:UBERON:0000468(multi-cellular organism)



Children

is a:UBERON:0000119 (cell layer),UBERON:0000412 (dermal papilla),UBERON:0001744 (lymphoid tissue),UBERON:0001758 (periodontium),UBERON:0002384 (connective tissue),UBERON:0002385 (muscle tissue),UBERON:0003091 (thyroid primordium),UBERON:0003104 (mesenchyme),UBERON:0003714 (neural tissue),UBERON:0004128 (optic vesicle),UBERON:0005291 (embryonic tissue),UBERON:0005292 (extraembryonic tissue),UBERON:0005388 (photoreceptor array),UBERON:0005426 (lens vesicle),UBERON:0005427 (corneal primordium),UBERON:0005497 (non-neural ectoderm),UBERON:0005932 (bulb of hair follicle),UBERON:0005933 (hair root sheath),UBERON:0005969 (reticulum trabeculare),UBERON:0007475 (matrix-based tissue),UBERON:0010536 (nephron progenitor),UBERON:0012429 (hemopoietic tissue),FF:10008-101B6 (Universal RNA - Mouse Normal Tissues Biochain, pool1)
derives from:FF:0000004 (tissue sample),FF:0000317 (mouse pregnant tissue sample),FF:0000998 (adult tissue sample),FF:0000999 (fetal tissue sample)
part of:FF:0000004 (tissue sample),FF:0000317 (mouse pregnant tissue sample),CL:0000864 (tissue-resident macrophage),FF:0000998 (adult tissue sample),FF:0000999 (fetal tissue sample)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Uberon ontology


Human (Homo sapiens)

  • 10000-101A1 (Clontech Human Universal Reference Total RNA, pool1)
  • 10001-101A3 (Clontech Mouse Universal Reference Total RNA, pool1)
  • 10002-101A5 (SABiosciences XpressRef Human Universal Total RNA, pool1)
  • 10003-101A7 (SABiosciences XpressRef Mouse Universal Total RNA, pool1)
  • 10004-101A9 (chicken embryo whole body, day10 (HH37))
  • 10006-101B2 (Universal RNA - Dog Normal Tissues Biochain, pool1)
  • 10007-101B4 (Universal RNA - Human Normal Tissues Biochain, pool1)
  • 10008-101B6 (Universal RNA - Mouse Normal Tissues Biochain, pool1)
  • 10009-101B8 (Universal RNA - Rat Normal Tissues Biochain, pool1)
  • 10010-101C1 (adipose tissue, adult, pool1)

... further results Mouse (Mus musculus)

  • 10000-101A1 (Clontech Human Universal Reference Total RNA, pool1)
  • 10001-101A3 (Clontech Mouse Universal Reference Total RNA, pool1)
  • 10002-101A5 (SABiosciences XpressRef Human Universal Total RNA, pool1)
  • 10003-101A7 (SABiosciences XpressRef Mouse Universal Total RNA, pool1)
  • 10004-101A9 (chicken embryo whole body, day10 (HH37))
  • 10006-101B2 (Universal RNA - Dog Normal Tissues Biochain, pool1)
  • 10007-101B4 (Universal RNA - Human Normal Tissues Biochain, pool1)
  • 10008-101B6 (Universal RNA - Mouse Normal Tissues Biochain, pool1)
  • 10009-101B8 (Universal RNA - Rat Normal Tissues Biochain, pool1)
  • 10010-101C1 (adipose tissue, adult, pool1)

... further results


Enrichment analysis: top 100 FFCP enriched with this ontology term TOP 100 FANTOM5 Cage Peaks enriched with UBERON:0000479 (tissue), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data


P-valueFFCPShort description
7.1e-18FFCP PHASE1:Hg19::chr2:145275162..145275202,-#_d87e74116553e4db084dd036854a3addp2@ZEB2
7.1e-18FFCP PHASE2:Hg19::chr2:145275162..145275202,-#_d87e74116553e4db084dd036854a3addp2@ZEB2
8.1e-17FFCP PHASE2:Hg19::chr12:66582919..66583077,+#_6c49b757455984cc549b3377120bf86cp1@IRAK3
8.1e-17FFCP PHASE1:Hg19::chr12:66582919..66583077,+#_6c49b757455984cc549b3377120bf86cp1@IRAK3
2.1e-16FFCP PHASE2:Hg19::chr9:125133293..125133309,+#_27ff11ad81116853db1ba1406b70d0adp2@PTGS1
2.1e-16FFCP PHASE1:Hg19::chr9:125133293..125133309,+#_27ff11ad81116853db1ba1406b70d0adp2@PTGS1
6.19e-16FFCP PHASE2:Hg19::chr5:88179017..88179046,-#_1fd6ea83bbbb20cd763a5f389fe344acp2@MEF2C
6.19e-16FFCP PHASE1:Hg19::chr5:88179017..88179046,-#_1fd6ea83bbbb20cd763a5f389fe344acp2@MEF2C
6.4e-16FFCP PHASE2:Hg19::chrX:11445856..11445943,-#_f50d0f3e9c0160287c2f7622e09e23d1p1@ARHGAP6
6.4e-16FFCP PHASE1:Hg19::chrX:11445856..11445943,-#_f50d0f3e9c0160287c2f7622e09e23d1p1@ARHGAP6
7.77e-16FFCP PHASE1:Hg19::chr20:23618584..23618603,-#_8254c2f83c6d3a84bbaf56087160fb0fp1@CST3
7.77e-16FFCP PHASE2:Hg19::chr20:23618584..23618603,-#_8254c2f83c6d3a84bbaf56087160fb0fp1@CST3
1.26e-15FFCP PHASE2:Hg19::chr6:119670919..119670943,-#_a41b922a6a38c233d952fb856afe11bdp1@MAN1A1
1.26e-15FFCP PHASE1:Hg19::chr6:119670919..119670943,-#_a41b922a6a38c233d952fb856afe11bdp1@MAN1A1
1.42e-15FFCP PHASE2:Hg19::chr12:51318790..51318817,+#_9126cd7c100e607a02adaa433e0fac96p1@METTL7A
1.42e-15FFCP PHASE1:Hg19::chr12:51318790..51318817,+#_9126cd7c100e607a02adaa433e0fac96p1@METTL7A
1.54e-15FFCP PHASE1:Hg19::chr10:45455207..45455263,+#_26c214f47dad4ecad3b083bfcee859b5p1@RASSF4
1.54e-15FFCP PHASE2:Hg19::chr10:45455207..45455263,+#_26c214f47dad4ecad3b083bfcee859b5p1@RASSF4
3.24e-15FFCP PHASE1:Hg19::chr4:8430152..8430200,-#_ed2f8fa4e7e60659e39be5ed10883153p1@ACOX3
3.24e-15FFCP PHASE2:Hg19::chr4:8430152..8430200,-#_ed2f8fa4e7e60659e39be5ed10883153p1@ACOX3
4.56e-15FFCP PHASE2:Hg19::chr5:114938090..114938226,-#_3287a75c4e846d77123707d26f82f3dcp1@TICAM2, p2@TMED7-TICAM2
4.56e-15FFCP PHASE1:Hg19::chr5:114938090..114938226,-#_3287a75c4e846d77123707d26f82f3dcp1@TICAM2, p2@TMED7-TICAM2
5.12e-15FFCP PHASE2:Hg19::chr2:230135937..230136016,-#_90ef144b7a2843b63a7748bf97b61ef9p1@PID1
5.12e-15FFCP PHASE1:Hg19::chr2:230135937..230136016,-#_90ef144b7a2843b63a7748bf97b61ef9p1@PID1
6.83e-15FFCP PHASE1:Hg19::chr4:159093517..159093533,-#_1acafb70c8eb74d76cd10ed82bf6c8cdp1@FAM198B
6.83e-15FFCP PHASE2:Hg19::chr4:159093517..159093533,-#_1acafb70c8eb74d76cd10ed82bf6c8cdp1@FAM198B
7.62e-15FFCP PHASE2:Hg19::chr5:88178983..88179012,-#_7ab6bc653185eb1b5324af7783bc7b69p1@MEF2C
7.62e-15FFCP PHASE1:Hg19::chr5:88178983..88179012,-#_7ab6bc653185eb1b5324af7783bc7b69p1@MEF2C
9.58e-15FFCP PHASE1:Hg19::chr9:113800705..113800781,-#_73832b96a8625c8d7bd7bb2444588f9ap1@LPAR1
9.58e-15FFCP PHASE2:Hg19::chr9:113800705..113800781,-#_73832b96a8625c8d7bd7bb2444588f9ap1@LPAR1
1.01e-14FFCP PHASE1:Hg19::chr4:185747114..185747128,-#_e7412fd89c68a25dd77fd9e481f7ee5ep1@ACSL1
1.01e-14FFCP PHASE2:Hg19::chr4:185747114..185747128,-#_e7412fd89c68a25dd77fd9e481f7ee5ep1@ACSL1
1.2e-14FFCP PHASE1:Hg19::chr19:36246113..36246265,+#_6f58953efbecd4a67d95c3863ac62a33p@chr19:36246113..36246265, +
1.2e-14FFCP PHASE2:Hg19::chr19:36246113..36246265,+#_6f58953efbecd4a67d95c3863ac62a33p@chr19:36246113..36246265, +
1.53e-14FFCP PHASE2:Hg19::chr11:27015649..27015680,+#_dc4b6d72ff2799ef550cbe6a56d2c3c4p1@FIBIN
1.53e-14FFCP PHASE1:Hg19::chr11:27015649..27015680,+#_dc4b6d72ff2799ef550cbe6a56d2c3c4p1@FIBIN
1.86e-14FFCP PHASE1:Hg19::chr2:145277640..145277771,-#_b08dc61f63193979848817a6debf4bbcp1@ZEB2
1.86e-14FFCP PHASE2:Hg19::chr2:145277640..145277771,-#_b08dc61f63193979848817a6debf4bbcp1@ZEB2
2.53e-14FFCP PHASE2:Hg19::chr17:8055699..8055729,-#_7ecf834e6977e1cff21d5e992bbbae10p2@PER1
2.53e-14FFCP PHASE1:Hg19::chr17:8055699..8055729,-#_7ecf834e6977e1cff21d5e992bbbae10p2@PER1
2.91e-14FFCP PHASE2:Hg19::chr15:74726283..74726306,-#_38753951f169bbc0b41ee098f5a802e9p1@SEMA7A
2.91e-14FFCP PHASE1:Hg19::chr15:74726283..74726306,-#_38753951f169bbc0b41ee098f5a802e9p1@SEMA7A
3.33e-14FFCP PHASE1:Hg19::chr3:142838629..142838697,+#_e34951ac9ceea5486177b4ba6cf6a106p1@CHST2
3.33e-14FFCP PHASE2:Hg19::chr3:142838629..142838697,+#_e34951ac9ceea5486177b4ba6cf6a106p1@CHST2
3.48e-14FFCP PHASE2:Hg19::chr18:5544022..5544045,-#_a288476f247dbdd47b2b8def1919f423p4@EPB41L3
3.48e-14FFCP PHASE1:Hg19::chr18:5544022..5544045,-#_a288476f247dbdd47b2b8def1919f423p4@EPB41L3
4.18e-14FFCP PHASE2:Hg19::chr1:32169580..32169599,-#_8606b7c9ea912875b775809857cce658p2@COL16A1
4.18e-14FFCP PHASE1:Hg19::chr1:32169580..32169599,-#_8606b7c9ea912875b775809857cce658p2@COL16A1
4.65e-14FFCP PHASE1:Hg19::chr1:209848749..209848764,+#_c360509826620bf4994df60729e9e9e1p1@G0S2
4.65e-14FFCP PHASE2:Hg19::chr1:209848749..209848764,+#_c360509826620bf4994df60729e9e9e1p1@G0S2
5.64e-14FFCP PHASE2:Hg19::chr13:77460532..77460548,-#_9913e6fce5aa05e1db4ac51d1c7d5ab3p1@KCTD12
5.64e-14FFCP PHASE1:Hg19::chr13:77460532..77460548,-#_9913e6fce5aa05e1db4ac51d1c7d5ab3p1@KCTD12
6.18e-14FFCP PHASE1:Hg19::chr19:36246086..36246335,-#_8cd197e0a892a5b41114ef4b409c344fp2@HSPB6
6.18e-14FFCP PHASE2:Hg19::chr19:36246086..36246335,-#_8cd197e0a892a5b41114ef4b409c344fp2@HSPB6
6.35e-14FFCP PHASE2:Hg19::chr8:48650715..48650735,-#_28e9ef2d2e30c75b6cf699a02dc479fbp1@CEBPD
6.35e-14FFCP PHASE1:Hg19::chr8:48650715..48650735,-#_28e9ef2d2e30c75b6cf699a02dc479fbp1@CEBPD
6.95e-14FFCP PHASE1:Hg19::chr7:120628737..120628818,+#_50225ab568aec74485620f8966586648p1@C7orf58
6.95e-14FFCP PHASE2:Hg19::chr7:120628737..120628818,+#_50225ab568aec74485620f8966586648p1@C7orf58
7.19e-14FFCP PHASE1:Hg19::chr4:185747194..185747242,-#_c72a46549e4adbb209699164c515aa5cp2@ACSL1
7.19e-14FFCP PHASE2:Hg19::chr4:185747194..185747242,-#_c72a46549e4adbb209699164c515aa5cp2@ACSL1
7.42e-14FFCP PHASE2:Hg19::chr17:66951474..66951550,-#_527db091d0e87994e3d4b9a393c983e4p1@ABCA8
7.42e-14FFCP PHASE1:Hg19::chr17:66951474..66951550,-#_527db091d0e87994e3d4b9a393c983e4p1@ABCA8
7.61e-14FFCP PHASE2:Hg19::chr12:91576561..91576613,-#_3870fdddfbac4db3b354cd74c67d8a73p1@DCN
7.61e-14FFCP PHASE1:Hg19::chr12:91576561..91576613,-#_3870fdddfbac4db3b354cd74c67d8a73p1@DCN
8.37e-14FFCP PHASE2:Hg19::chr18:5543988..5544019,-#_0ef80e070280302b8117312c2494ba50p1@EPB41L3
8.37e-14FFCP PHASE1:Hg19::chr18:5543988..5544019,-#_0ef80e070280302b8117312c2494ba50p1@EPB41L3
1.12e-13FFCP PHASE1:Hg19::chr9:113800467..113800520,-#_90108eb7b804ffee73d6fe85ffda7bb8p2@LPAR1
1.12e-13FFCP PHASE2:Hg19::chr9:113800467..113800520,-#_90108eb7b804ffee73d6fe85ffda7bb8p2@LPAR1
1.23e-13FFCP PHASE1:Hg19::chr6:119670450..119670481,-#_70eec7cbe71eb3cc8e39deeb45a1f9cep1@X74837
1.23e-13FFCP PHASE2:Hg19::chr6:119670450..119670481,-#_70eec7cbe71eb3cc8e39deeb45a1f9cep1@X74837
1.8e-13FFCP PHASE1:Hg19::chr2:40679186..40679297,-#_33c8bd92691b096faf8818c24789ac63p1@SLC8A1
1.8e-13FFCP PHASE2:Hg19::chr2:40679186..40679297,-#_33c8bd92691b096faf8818c24789ac63p1@SLC8A1
2.22e-13FFCP PHASE2:Hg19::chr5:78281092..78281154,-#_be8af8681971bfcb5c3460fa87c1da59p1@ARSB
2.22e-13FFCP PHASE1:Hg19::chr5:78281092..78281154,-#_be8af8681971bfcb5c3460fa87c1da59p1@ARSB
2.69e-13FFCP PHASE2:Hg19::chr9:125133315..125133339,+#_24b2bc406606faedb95e4a1419374931p1@PTGS1
2.69e-13FFCP PHASE1:Hg19::chr9:125133315..125133339,+#_24b2bc406606faedb95e4a1419374931p1@PTGS1
2.77e-13FFCP PHASE1:Hg19::chr19:36247921..36247937,-#_063f90a655aa35473db4ad0d08c2eaefp1@HSPB6
2.77e-13FFCP PHASE2:Hg19::chr19:36247921..36247937,-#_063f90a655aa35473db4ad0d08c2eaefp1@HSPB6
2.88e-13FFCP PHASE2:Hg19::chr18:77711625..77711675,-#_bfce42e1cfacecc47bdd9ef24b2b42c1p1@PQLC1
2.88e-13FFCP PHASE1:Hg19::chr18:77711625..77711675,-#_bfce42e1cfacecc47bdd9ef24b2b42c1p1@PQLC1
2.91e-13FFCP PHASE1:Hg19::chr3:187463248..187463264,-#_594004b4c90c4671520adb68f72f7cfep1@BCL6
2.91e-13FFCP PHASE2:Hg19::chr3:187463248..187463264,-#_594004b4c90c4671520adb68f72f7cfep1@BCL6
3.18e-13FFCP PHASE2:Hg19::chr2:160654706..160654744,-#_af4521461de2737c3ade81c5d68c859ep1@CD302
3.18e-13FFCP PHASE1:Hg19::chr2:160654706..160654744,-#_af4521461de2737c3ade81c5d68c859ep1@CD302
3.87e-13FFCP PHASE2:Hg19::chr10:33623460..33623478,-#_49032a210bdc3675780b32e0bc1e1172p3@NRP1
3.87e-13FFCP PHASE1:Hg19::chr10:33623460..33623478,-#_49032a210bdc3675780b32e0bc1e1172p3@NRP1
5.08e-13FFCP PHASE1:Hg19::chr6:35310395..35310410,+#_cd0e8d17aac1b2b911bd1b4df7c6254dp2@PPARD
5.08e-13FFCP PHASE2:Hg19::chr6:35310395..35310410,+#_cd0e8d17aac1b2b911bd1b4df7c6254dp2@PPARD
5.11e-13FFCP PHASE1:Hg19::chr11:3186494..3186545,-#_c83f88011d939d3d9db97225cac12de2p1@OSBPL5
5.11e-13FFCP PHASE2:Hg19::chr11:3186494..3186545,-#_c83f88011d939d3d9db97225cac12de2p1@OSBPL5
5.41e-13FFCP PHASE2:Hg19::chr15:90358048..90358103,-#_4b13681a9f0c85f9a24ae84420aa4640p1@ANPEP
5.41e-13FFCP PHASE1:Hg19::chr15:90358048..90358103,-#_4b13681a9f0c85f9a24ae84420aa4640p1@ANPEP
5.45e-13FFCP PHASE1:Hg19::chr19:14228521..14228536,-#_49956c9acfffe60360aacaefebff0200p2@PRKACA
5.45e-13FFCP PHASE2:Hg19::chr19:14228521..14228536,-#_49956c9acfffe60360aacaefebff0200p2@PRKACA
5.62e-13FFCP PHASE2:Hg19::chr1:145039949..145039967,-#_e8baccde2d334fb25e97e9cfc1a9fc96p1@PDE4DIP
5.62e-13FFCP PHASE1:Hg19::chr1:145039949..145039967,-#_e8baccde2d334fb25e97e9cfc1a9fc96p1@PDE4DIP
5.69e-13FFCP PHASE2:Hg19::chr11:118478313..118478358,+#_ca90246815652f512ec55e87f8786bd8p1@PHLDB1
5.69e-13FFCP PHASE1:Hg19::chr11:118478313..118478358,+#_ca90246815652f512ec55e87f8786bd8p1@PHLDB1
6.13e-13FFCP PHASE2:Hg19::chr2:145274900..145274934,-#_a3ec8a66b71392b112c8612241f08a37p4@ZEB2
6.13e-13FFCP PHASE1:Hg19::chr2:145274900..145274934,-#_a3ec8a66b71392b112c8612241f08a37p4@ZEB2